These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23348862)

  • 1. Revival of PFA-100--how far is it useful for the monitoring of ADP receptor antagonists?
    Golanski J; Syska K; Watala C
    Thromb Haemost; 2013 Mar; 109(3):564-5. PubMed ID: 23348862
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of poor biological response to clopidogrel: a systematic review.
    Mallouk N; Labruyère C; Reny JL; Chapelle C; Piot M; Fontana P; Gris JC; Delavenne X; Mismetti P; Laporte S
    Thromb Haemost; 2012 Mar; 107(3):494-506. PubMed ID: 22273694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet ADP inhibitors in ischemic heart disease.
    Verheugt FW
    Rev Port Cardiol; 2003 May; 22(5):749-51. PubMed ID: 12940188
    [No Abstract]   [Full Text] [Related]  

  • 4. Using the Platelet Function Analyzer-100 for monitoring aspirin therapy.
    Poulsen TS; Mickley H; Korsholm L; Licht PB; Haghfelt T; Jørgensen B
    Thromb Res; 2007; 120(2):161-72. PubMed ID: 17052745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive antiplatelet therapy for reduction of ischaemic events.
    Ramaraj R
    Lancet; 2008 Aug; 372(9638):531; author reply 532. PubMed ID: 18707975
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment.
    Paniccia R; Antonucci E; Gori AM; Marcucci R; Poli S; Romano E; Valente S; Giglioli C; Fedi S; Gensini GF; Abbate R; Prisco D
    Am J Clin Pathol; 2007 Jul; 128(1):143-9. PubMed ID: 17580282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ADP receptor blockers: new insights in the therapy and prophylaxis of ischemic heart disease].
    Gassanov N; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2011 Jul; 136(27):1433-7. PubMed ID: 21713722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel].
    Helø OH; Madsen JK; Kastrup J
    Ugeskr Laeger; 2004 Apr; 166(18):1659-62. PubMed ID: 15174400
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased use of acid-suppressing drugs before the occurrence of ischemic events: a potential source of confounding in recent observational studies.
    Blackburn DF; Lamb DA; Mcleod MM; Eurich DT
    Pharmacotherapy; 2010 Oct; 30(10):985-93. PubMed ID: 20874035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease.
    Storey RF; Wilcox RG; Heptinstall S
    Platelets; 2002 Nov; 13(7):407-13. PubMed ID: 12487788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy for ischemic heart disease.
    Steimle AE
    N Engl J Med; 2004 May; 350(20):2101-2; author reply 2101-2. PubMed ID: 15141055
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of CURE trial for acute coronary syndrome.
    Mitka M
    JAMA; 2001 Apr; 285(14):1828-9. PubMed ID: 11308379
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acute coronary syndromes.
    Peverill RE; Moir S
    N Engl J Med; 2002 Jan; 346(3):206-8. PubMed ID: 11797721
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of acute coronary syndromes.
    Owen A
    N Engl J Med; 2002 Jan; 346(3):206-8. PubMed ID: 11796858
    [No Abstract]   [Full Text] [Related]  

  • 15. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis?
    von Lewinski F; Riggert J; Paulus W
    J Stroke Cerebrovasc Dis; 2009; 18(2):111-5. PubMed ID: 19251186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome.
    Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Romero-Barra M; Camoin L; Lambert M; Juhan-Vague I; Bonnet JL; Alessi MC
    Thromb Haemost; 2007 Feb; 97(2):212-7. PubMed ID: 17264949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
    Dyszkiewicz-Korpanty A; Olteanu H; Frenkel EP; Sarode R
    Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular pharmacology].
    Stiefelhagen P
    Internist (Berl); 2004 Oct; 45(10):1205-10. PubMed ID: 15322708
    [No Abstract]   [Full Text] [Related]  

  • 19. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
    Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
    Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute coronary syndromes.
    Tahiliani N; Trivedi A; Deshmukh HG
    N Engl J Med; 2002 Jan; 346(3):206-8. PubMed ID: 11797722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.